The newly passed Bill is 45 pages long and makes many amendments to the intellectual property legislation relating to Patents, Trade Marks, Registered Designs and Plant Breeders Rights in Australia. Links to copies of the Bill and Explanatory Memorandum can be found in my earlier article ‘Spring-boarding to catch up with the rest of the world’.
The following table provides a summary of the most important changes. (The changes to the Designs and Plant Breeders Rights deal only with formalities and are not included.)
Provides for exemplary damages for patent infringement in relation to:
(a) flagrant infringement;
(b) the need to deter similar infringements;
(c) the conduct of the infringing party after infringement or after being informed of the allegation of infringement;
(d) the benefit accrued to the infringing party; and
(e) any other relevant matter.
Exemplary damages may be sought in relation to any infringement which occurs after this section comes into force. So, it will not apply to currently pending court proceedings unless further acts of infringement occur.
Clarification of the exemption to patent infringement for prior secret use of an invention by a third party. (Prior public use does not require the exemption as it would destroy validity.)
Amongst other things, the section extends the prior user right to all acts of exploitation, (not just those which had been undertaken prior to the priority date of the patent). It also allows transfer of the prior user right to another.
The exemption will only apply to patents granted after the section comes into force.
This section which is long-awaited by generic drug manufacturers, provides an exemption from infringement of a ‘pharmaceutical patent’ if the acts done are solely for obtaining regulatory approval in Australia or elsewhere. (A ‘pharmaceutical patent’ is defined as one which claims a pharmaceutical substance or a method, use or product relating to one).
While the exemption applies to export for Australian regulatory purposes, it does not apply to export of goods from Australia, unless the term of the patent has been extended and the goods contain a pharmaceutical substance per se (or produced by a process that involves the use of a recombinant DNA technology).
Previously, springboarding was only allowed in relation to patents which had been extended.
Contravention of Australian competition law in connection with the patent as a ground for grant of a compulsory license. Specifically relates to contraventions of Part IV of the Trade Practices Act (restrictive trade practices).
This applies to any conduct which occurs after commencement of these sections.
Clarifies that the claims of Innovation Patents must define the invention. (The same requirement applies to Standard Patents.)
Clarifies timing for making a divisional application for an innovation patent.
The Registrar of Trade Marks now has the power to revoke acceptance of a Trade Mark prior to registration.
After giving the trade mark owner and other interested parties sufficient notice, the Registrar of Trade Marks may revoke a Trade Mark after registration. Grounds for revocation under this section are quite broad, and include merely that it is reasonable to do so, taking account of all the circumstances.
Registration process for certification trade marks (CTM – a trade mark used to distinguish goods or services which have met specified certification requirements).
Establish a regime for availability and confidentiality of documents filed at the Trade Marks Office.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
IP is the legal property in the innovation in your business and it is that which drives your revenue and profit growth.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).